Global Med Technologies(R), Inc. Adds New Jersey Healthcare System to Strong Northeast Client Base
June 17 2008 - 8:45AM
PR Newswire (US)
CentraState becomes 109th Site in Region DENVER, June 17
/PRNewswire-FirstCall/ -- Global Med Technologies(R), Inc. ("Global
Med" or the "Company") (OTC:GLOB) (BULLETIN BOARD: GLOB) , an
international e-Health, medical information technology company,
today announced that its Wyndgate Technologies(R) division has
licensed its SafeTrace Tx(R) transfusion management software to
CentraState Healthcare System ("CentraState") of Freehold, New
Jersey. Terms of the agreement were not disclosed. (Logo:
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO) Cynthia
Kasten, CLS, MT, BS, Laboratory Manager/Blood Bank Supervisor for
CentraState Medical Center stated, "We noticed Wyndgate's products
in a professional journal and decided to research their transfusion
system for our blood bank. After applying the American Association
of Blood Bank's ("AABB") Quality System Essentials point system to
assess various software systems, we found that Wyndgate's SafeTrace
Tx software met our hospital's criteria." Ms. Kasten continued,
"The Patient-At-A-Glance(R) bar was a major eye-catching feature
which will allow us to view critical data at each step in the
process. With SafeTrace Tx, we expect to enhance the level of
patient safety through the extensive array of test safety checks
and make our process more efficient." SafeTrace Tx is a blood
management software system designed to raise the standard of care
for patients, improve safety, reduce waste and increase efficiency.
SafeTrace Tx provides comprehensive tracking of orders, specimens,
blood products, derivatives, and accessories with a complete
testing and transfusion history in one consolidated record. These
complex features will assist CentraState in improving their
processes, making it easier for their technicians to provide
appropriate blood products for their patients. Wm. Scott Dustin,
Vice President of Sales and Marketing at Wyndgate Technologies,
commented, "We are excited to have been chosen to assist
CentraState with enhancing patient safety in their hospital.
Working with CentraState staff during the contracting process has
been a pleasure. We are looking forward to supporting CentraState
with quality products and services as they continue to provide
excellent, advanced healthcare to patients in their community."
About CentraState Healthcare System CentraState Healthcare System
is a private, not-for-profit health organization with an acute-care
medical center licensed for 271 beds, a new 171,000-square-foot
outpatient center and three senior living communities. In 2005
CentraState Medical Center became affiliated with the University of
Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical
School as a teaching hospital. In the same year the hospital was
awarded Magnet designation for nursing excellence by The American
Nurses Credentialing Center (ANCC) of the American Nursing
Association. About Global Med Technologies, Inc. Global Med
Technologies(R), Inc. is an international e-Health medical
information technology company providing information management
software products and services to the healthcare industry. Its
Wyndgate Technologies(R) division is a leading supplier of
information management systems to U.S. and international blood
centers and hospital transfusion centers. Each year, Wyndgate's
products and services manage more than eight million blood
components, representing over 27% of the U.S. blood supply.
Wyndgate's products are also being used in Canada, Africa, and the
Caribbean. Wyndgate's software provides Vein-to-Vein(R) tracking
from donor collection to patient transfusion through its Donor
Doc(TM) interactive donor health history questionnaire, ElDorado
Donor(TM) and SafeTrace(R) donor management systems, to its
SafeTrace Tx(R) advanced transfusion management system. Global
Med's PeopleMed(R), Inc. subsidiary provides custom software
validation, consulting and compliance solutions to hospitals and
blood centers. PeopleMed's in-depth knowledge of Wyndgate's
products and the blood banking industry results in cost-effective
validation services, which leads to more efficient software
implementations and upgrades for our customers. For more
information about Global Med's products and services, please call
800-WYNDGATE or visit http://www.globalmedtech.com/,
http://www.peoplemed.com/ and http://www.wyndgate.com/. This news
release may include statements that constitute forward-looking
statements, usually containing the words "believe," "estimate,"
"project," "expects" or similar expressions. These statements are
made pursuant to the safe harbor provisions of the Private
Securities Litigation Reform Act of 1995. Forward-looking
statements inherently involve risks and uncertainties that could
cause actual results to differ materially from the forward-looking
statements. By making these forward-looking statements, the Company
undertakes no obligation to update these statements for revisions
or changes after the date of this news release.
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO
http://photoarchive.ap.org/ DATASOURCE: Global Med Technologies(R),
Inc. CONTACT: Michael I. Ruxin, M.D. of Global Med Technologies,
Inc., +1-303-238-2000, ; Investors, Paul Holm, President of
portfoliopr.inc, +1-212-888-4570, , for Global Med Technologies,
Inc. Web site: http://www.globalmedtech.com/
Copyright